1. W.G. Nayler, The role of calcium in the ischemic myocardium, Am. J. Pathol. 102:262 (1981).
2. J.T. Willerson, A. Mukherjee, K. Chien, C. Ezquierdo, and L.M. Buja, Calcium and acute myocardial infraction, in: “Calcium Antagonists and Cardiovascular Disease”, L.H. Opie, ed., Raven Press, New York, p 257 (1984).
3. K.A. Reimer and R.B. Jennings, The “wavefront phenomenon” of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral blood flow, Lab. Invest. 40:633 (1979).
4. L.M. Buja, A.J. Tofe, P.V. Kulkarni, A. Mukherjee, R.W. Parkey, M.D. Francis, F.J. Bonte, and J.T. Willerson, Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues, J. Clin. Invest. 60:724 (1977).
5. J.T. Willerson, F. Scales, A. Mukherjee, M.R. Platt, G.H. Templeton, G.C. Fink, and L.M. Buja, Abnormal myocardial fluid retention as an early manifestation of ischemic injury, Am. J. Pathol. 87:159 (1977).